Twice named among the top 100 inspiring people by PharmaVOICE magazine, Terrell "Terry" Herring has served as president of commercial operations for Mission Pharmacal Company since 2010. Currently residing in Pennsylvania, Terrell "Terry" Herring enjoys both college and professional sports, especially basketball and football. The parallels between sports and business are many yet Herring draws particular inspiration from three main commonalities. First, the importance of working together as a team. It is possible to have the best players and not win a championship. Teams win titles, not players. Being a team is not always enough, however, both in sports and business the best results are achieved by formulating and working to follow a winning game plan. It is important to develop a blueprint for success and actually have a clear vision of how to obtain the desired results. When developing a game plan, it is important to try to factor in any potential obstacles. Inevitably, however, situations can arise that are unexpected and unanticipated. In those instances, it is vitally important to be adaptable. Being able to update plans when roadblocks appear is essential to developing a consistently winning team. All of these attributes can also be applied to business, and Terrell Herring has made that connection and strives to infuse his work life with those three commonalities every day.
0 Comments
Based in Doylestown, Pennsylvania, Terrell (“Terry”) Herring guides a number of pharmaceutical industry-focused enterprises within the Mission Family of Companies. Terrell Herring maintains a strong community focus and has long contributed to the fundraising efforts of March for Babies and the March of Dimes. One of the current efforts of the latter nonprofit, which has focused on pregnancy and infant health for generations, is on improving the United States’ track record in preterm birth prevention. While the rates of premature births have decreased over the past decade, this has not extended equally across the country, and residents of “high population/high-burden” areas still experience double-digit levels of preterm birth. The current campaign aims to reduce the rate of preterm births, which stand as a leading cause of infant mortality and lifelong disabilities, to 5.5 percent by 2030. If successful, it will effectively spare 1.3 million babies the health problems associated with premature birth and reduce associated medical cost burdens in ways that benefit society. |
AuthorTerrell Herring began working at Mission Pharmacal Company in 2010, bringing more than 25 years of experience in the pharmaceutical industry to his role as President of Commercial Operations. Archives
February 2018
Categories
All
|